Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital is a clinical research site located in New Brunswick, New Jersey, United States 08903.
Crixeo Clinical Trials Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.
Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital has participated in 143 clinical trials with 70 currently active.
Therapeutic areas: B Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, Acute Undifferentiated Leukemia.
Sponsors: National Cancer Institute (NCI), Children's Oncology Group, Alliance for Clinical Trials in Oncology.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in New Jersey · View every site in New Brunswick
Trust Score: 88/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital has 143 clinical trials on record, with 70 currently active. Their work covers B Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, Acute Undifferentiated Leukemia.
Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.